Teligent Breaks Ground on Manufacturing and R&D Expansion
Teligent is expanding its manufacturing and R&D complex in New Jersey.
Teligent, a New Jersey-based specialty generic-drug pharmaceutical company, held a formal groundbreaking ceremony for the ongoing expansion of its manufacturing and research and development complex in Buena, NJ, the company said in a July 6, 2016 press release. The $45â50 million project will increase the facility's footprint by more than 75,000 ft2, a 200% increase to current operations. Once completed, the expansion will include the installation of a new isolator-based sterile injectable manufacturing suite and will deliver a significant increase to the company's manufacturing capacity for topical pharmaceutical products.
''We are making very good progress on our expansion, and this ceremony was an opportunity to celebrate what we are building together,'' commented Teligent's president and CEO, Jason Grenfell-Gardner, in the press release. ''We continue to be on track for project completion by the end of 2017.''
Source: Teligent
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
PostEra Expands Pfizer Partnership with AI Lab and ADC Collaborations
January 8th 2025The AI Lab was launched almost exactly three years ago and has produced several programs so far, at least one of which achieved its first scientific stage gate 40% faster than the teams originally forecasted.
